Fig. 1From: Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 geneStudy flow chart. A group of 925 patients at Kanazawa University Hospital treated using ezetimibe 10 mg/day on top of atorvastatin 10 mg/day between April 2006 to March 2017 were investigated. We excluded 103 patients because of missing clinical data, 178 individuals because their status of clinical FH, 271 individuals lacking genetic analyses on ABCG5/ABCG8 genes, 52 individuals with genetic-FH. Finally, a cohort of 321 participants with a mean age of 51 ± 18 years was included in this retrospective analysisBack to article page